Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 24NIH 10NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 8Neuroblastoma 7Leukemia, Myeloid, Acute 6Sarcoma 5Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Rhabdomyosarcoma 3Malignant mesenchymal tumor 3Multiple Myeloma 2Ganglioneuroblastoma 2Congenital Abnormalities 2Brain Neoplasms 2Stomach Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Mouth Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Rituximab 13Cyclophosphamide 12Vincristine 11Prednisone 11Doxorubicin 8Radiotherapy 6Immunohistochemistry 5VAP-cyclo protocol 4Peripheral Blood Stem Cell Transplantation 4Gene Expression Profiling 4Etoposide 4Amplified Fragment Length Polymorphism Analysis 4tositumomab I-131 3Polymerase Chain Reaction 3Microarray Analysis 3Methotrexate 3Cytarabine 3Melphalan 2Interferon-alpha 2Filgrastim 2Carmustine 2Bortezomib 2Bendamustine Hydrochloride 2thymoglobulin 1sargramostim 1pegfilgrastim 1merphos 1liposomal amphotericin B 1ixabepilone 1ibritumomab tiuxetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Follicular × sargramostim × Clear all
NCT00389818 2018-06-06

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Completed
43 enrolled 7 charts
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡